CY1321A - 1,4-dihydropyridines their preparation and pharmaceutical compositions containing them - Google Patents

1,4-dihydropyridines their preparation and pharmaceutical compositions containing them

Info

Publication number
CY1321A
CY1321A CY1321A CY132179A CY1321A CY 1321 A CY1321 A CY 1321A CY 1321 A CY1321 A CY 1321A CY 132179 A CY132179 A CY 132179A CY 1321 A CY1321 A CY 1321A
Authority
CY
Cyprus
Prior art keywords
dihydropyridines
preparation
pharmaceutical compositions
compositions containing
pharmaceutical
Prior art date
Application number
CY1321A
Other languages
English (en)
Original Assignee
Sandoz Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz Ltd filed Critical Sandoz Ltd
Publication of CY1321A publication Critical patent/CY1321A/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/04Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/08Vasodilators for multiple indications
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/04Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
CY1321A 1978-12-18 1979-12-14 1,4-dihydropyridines their preparation and pharmaceutical compositions containing them CY1321A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH1283578A CH639659A5 (de) 1978-12-18 1978-12-18 Neue 1,4-dihydropyridinderivate, deren herstellung und verwendung.

Publications (1)

Publication Number Publication Date
CY1321A true CY1321A (en) 1986-06-27

Family

ID=4386824

Family Applications (1)

Application Number Title Priority Date Filing Date
CY1321A CY1321A (en) 1978-12-18 1979-12-14 1,4-dihydropyridines their preparation and pharmaceutical compositions containing them

Country Status (18)

Country Link
JP (1) JPS5583783A (cs)
AU (1) AU536055B2 (cs)
BE (1) BE880591A (cs)
CH (1) CH639659A5 (cs)
CY (1) CY1321A (cs)
DE (1) DE2949491A1 (cs)
FR (1) FR2444681A1 (cs)
GB (2) GB2103203B (cs)
HK (1) HK16086A (cs)
IE (1) IE49496B1 (cs)
IT (1) IT1164097B (cs)
KE (1) KE3593A (cs)
MY (1) MY8500130A (cs)
NL (2) NL193066C (cs)
NZ (1) NZ192422A (cs)
SE (1) SE445219B (cs)
SG (1) SG97585G (cs)
ZA (1) ZA796842B (cs)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3022030A1 (de) * 1980-06-12 1981-12-17 Bayer Ag, 5090 Leverkusen 4-thiazol- bzw. 4-imidazol-substituierte, 1,4-dihydropyridine, verfahren zu deren herstellung sowie diese enthaltende arzneimittel
CH655658B (cs) * 1980-09-18 1986-05-15
EP0080220B1 (en) * 1981-11-17 1986-02-19 FISONS plc Dihydropyridines, methods for their production and their formulation and use as pharmaceuticals
ZA83959B (en) * 1982-03-10 1984-09-26 Sandoz Ltd 1,4-dihydropyridine derivatives,their preparation and pharmaceutical compositions containing them
US4414213A (en) * 1982-03-22 1983-11-08 Mead Johnson & Company Dihydropyridyl cyclic imidate esters and their pharmaceutical use
FR2528431B1 (fr) * 1982-06-15 1986-01-10 Sandoz Sa Nouveaux derives de la 1,4-dihydropyridine, leur preparation et leur utilisation comme medicaments
IL68975A (en) * 1982-06-15 1987-01-30 Sandoz Ag 4-(2,1,3-benzoxadiazol-4-yl)-1,4-dihydropyridine-3,5-dicarboxylic acid ester derivatives in optically active form,their preparation and pharmaceutical compositions containing them
JPS5978186A (ja) * 1982-10-27 1984-05-04 Yoshitomi Pharmaceut Ind Ltd 1,4−ジヒドロピリジン−3,5−ジカルボン酸エステル誘導体
US4794111A (en) * 1984-05-23 1988-12-27 Bayer Aktiengesellschaft Dihydropyridine preparations containing β-blockers
HU198844B (en) * 1984-06-14 1989-12-28 Sandoz Ag Process for producing new galenic pharmaceutical composition ensuring retarded release of active ingredient
US5260321A (en) * 1984-11-12 1993-11-09 Sandoz Ltd. Use of 1,4-dihydropyridine derivatives and combinations thereof with calcitonins
HU197201B (en) * 1985-10-01 1989-03-28 Sandoz Ag Process for producing oral pharmaceutical compositions of controlled solubility of the active components
DE3542794A1 (de) * 1985-12-04 1987-06-11 Bayer Ag Antihypertensives kombinationspraeparat
GB8626217D0 (en) * 1986-11-03 1986-12-03 Sandoz Ltd Pharmaceutical compositions
US4816263A (en) * 1987-10-02 1989-03-28 Alza Corporation Dosage form for treating cardiovascular diseases comprising isradipine
KR940003492B1 (ko) * 1988-10-27 1994-04-23 주식회사 유한양행 1,4-디하이드로피리딘유도체 및 그의 제조방법
DE4222770A1 (de) * 1992-07-10 1994-01-13 Bayer Ag Lichtaktivierbare 1-(2-Nitrobenzyl)-substituierte 1,4-Dihydropyridine
IL163666A0 (en) 2002-02-22 2005-12-18 New River Pharmaceuticals Inc Active agent delivery systems and methods for protecting and administering active agents
WO2005023787A1 (en) * 2003-09-10 2005-03-17 Shasun Chemicals And Drugs Limited Process for the manufacture of 2,1,3-benzoxadiazole-4-carboxaldehyde
CN103613584B (zh) * 2013-11-27 2016-04-27 沈阳药科大学 一种伊拉地平合成产物后处理的方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1670824C3 (de) * 1967-03-20 1978-08-03 Bayer Ag, 5090 Leverkusen 1,4-Dihydropyridin-33-dicarbonsäurealkylester
FR2320750A1 (fr) * 1975-08-12 1977-03-11 Hexachimie Dihydro-1,4 pyridines et leur application therapeutique
DE2616991A1 (de) * 1976-04-17 1977-10-27 Bayer Ag Heterocyclisch-substituierte schwefelhaltige dihydropyridine, mehrere verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel
JPS5373327A (en) * 1976-12-13 1978-06-29 Matsushita Electric Ind Co Ltd Power source system
DK149855C (da) * 1977-06-20 1987-04-21 Sandoz Ag Analogifremgangsmaade til fremstilling af 1,4-dihydropyridinderivater

Also Published As

Publication number Publication date
IE49496B1 (en) 1985-10-16
AU5389679A (en) 1980-06-26
IT7951095A0 (it) 1979-12-14
GB2103203A (en) 1983-02-16
IT1164097B (it) 1987-04-08
GB2037766A (en) 1980-07-16
JPS5583783A (en) 1980-06-24
CH639659A5 (de) 1983-11-30
SG97585G (en) 1986-07-18
NZ192422A (en) 1982-09-14
ZA796842B (en) 1981-07-29
DE2949491A1 (de) 1980-06-26
FR2444681B1 (cs) 1982-10-29
NL7909024A (nl) 1980-06-20
NL193066C (nl) 1998-09-08
SE445219B (sv) 1986-06-09
BE880591A (fr) 1980-06-13
DE2949491C2 (cs) 1988-10-27
GB2103203B (en) 1983-06-08
GB2037766B (en) 1983-02-16
SE7910188L (sv) 1980-06-19
KE3593A (en) 1986-02-07
NL193066B (nl) 1998-05-06
FR2444681A1 (fr) 1980-07-18
NL990014I1 (nl) 1999-07-01
JPH0369910B2 (cs) 1991-11-05
HK16086A (en) 1986-03-14
MY8500130A (en) 1985-12-31
AU536055B2 (en) 1984-04-19
IE792445L (en) 1980-06-18

Similar Documents

Publication Publication Date Title
IL58123A (en) 4,5-diaryl-2-nitroimidazoles,their preparation and pharmaceutical compositions containing them
IL56992A (en) N-heterocyclyl-4-piperidinamines,their preparation and pharmaceutical compositions containing them
IL53639A (en) 1,4-dihydropyridine derivatives,their preparation and pharmaceutical compositions containing them
IL57708A0 (en) Aminopropoxyindole derivatives,their preparation and pharmaceutical compositions containing them
NZ190299A (en) 1,2,4-trizole -3,5- diamines and pharmaceutical compositions
NZ190745A (en) Mercapto-substituted -2,3,4,5-tetrahydro-1h-3-benzazepines and pharmaceutical compositions
GB2037766B (en) 1,4-dihydropyridines their preparation and pharmaceutical compositions containing them
IL57081A0 (en) Substituted 1,3-diarly-2-imino-imidazolidines and hexahydropyrimidines their preparation and pharmaceutical compositions containing them
DE2965287D1 (en) Bis-imidazoles, their preparation and pharmaceutical compositions containing them
IL57297A (en) 4-amino-2-piperidinoquinazoline derivatives,their preparation and pharmaceutical compositions containing them
IL56856A (en) 4,5-diaryl-pyrrole derivatives,their preparation and pharmaceutical compositions containing them
IL54358A (en) 1-substituted-3-amino-6,7-dialkoxy-1h-1,2,4-benzothiadiazine-1-oxides,their preparation and pharmaceutical compositions containing them
IL56686A0 (en) Acylaminoalkyl-syanoguanidines,their preparation and pharmaceutical compositions containing them
IL57891A0 (en) Alkylthiophenoxyalkylamines,their preparation and pharmaceutical compositions containing them
IL56816A0 (en) N-phenylaniline derivatives,their preparation and pharmaceutical compositions containing them
IL57754A0 (en) Benzopyranotriazoles,their preparation and pharmaceutical compositions containing them
IL57720A0 (en) Phenylpiperidine derivatives,their preparation and pharmaceutical compositions containing them
IL56913A (en) Sprio-steroid-oxazolidinone derivatives,their preparation and pharmaceutical compositions containing them
IL56890A0 (en) 2-amino-carbazole derivatives,their preparation and pharmaceutical compositions containing them
IL56728A (en) Androstadienes,their preparation and pharmaceutical compositions containing them
DE2963868D1 (en) Carbostyrile derivatives, their preparation and pharmaceutical compositions containing them
IL57854A0 (en) Substituted 2-phenylamino-imidazoline-(2)-derivatives,their preparation and pharmaceutical compositions containing them
IL56075A0 (en) Novel arylaminoimidazoline derivatives,their preparation and pharmaceutical compositions containing them
HK12384A (en) Novel veratramides,their preparation and pharmaceutical compositions containing them
IL56349A0 (en) 3-aminopropoxyaryl derivatives, their preparation and pharmaceutical compositions containing them